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We compared 61 Shiga toxin–producing Escherichia 
coli (STEC) serogroups from 448 food isolates with 71 STEC 
serogroups from 1,447 isolates from patients in Germany. 
Two thirds (41/61), representing 72% of food isolates, were 
also found in patients. Serogroups typically isolated from 
patients with hemolytic uremic syndrome were rarely found 
in food.
S
higa toxin–producing Escherichia coli (STEC) of se-
rogroups other than O157 (non-O157 STEC) account 
for 80% of STEC gastroenteritis reports in Germany’s 
national surveillance database (1). Some of the non-O157 
serogroups unequivocally cause disease comparable in se-
verity to that caused by STEC O157, such as the hemolytic 
uremic syndrome (HUS) (2). Numerous, but not all, STEC 
serogroups have been linked with human disease.
Food is an important transmission vehicle for human 
STEC infection, especially in outbreaks (3), and many 
different STEC serogroups are isolated from food (4). 
Yet the public health relevance of many of these STEC 
serogroups, which includes their ability to cause human 
disease and the frequency with which this may occur, has 
not been investigated.
In Germany, identiﬁ  cation of STEC in patients’ stool 
and in food is based on detection of Shiga toxin or of a 
Shiga toxin gene and subsequent isolation of STEC strains 
(4,5). This allows, in principle, ascertainment of all STEC 
strains, independent of their serogroup. To assess the public 
health relevance of STEC isolated from food, we compared 
those strains with those isolated from patients.
The Study
Information on STEC isolates from food came from 2 
sources. The ﬁ  rst source was the Federal Institute for Risk 
Assessment, which received isolates from German govern-
mental food inspection laboratories for strain characteriza-
tion from 2005 through 2007 (food source 1). These STEC 
isolates originated from routine food samples taken by food 
safety authorities across Germany, according to a nation-
wide sampling scheme that focused during the sampling 
period mainly on red meat, ground raw meat, and stabilized 
meat products. The second source was the Max-Rubner In-
stitute in Germany, which had conducted a series of inves-
tigations in conveniently selected meat-processing compa-
nies in Germany from 1996 through 2004 (food source 2). 
Information on STEC isolates from patients came from a 
laboratory-based sentinel in existence from 1999 through 
2004, coordinated by Germany’s National Reference Cen-
ter. The sentinel has been described elsewhere (6). In brief, 
private laboratories across Germany agreed to screen stool 
specimens of gastroenteritis patients for the presence of 
Shiga toxin 1 and Shiga toxin 2 with an enzyme immunoas-
say if predeﬁ  ned criteria were met (e.g., patients with diar-
rhea were <5 years of age, bloody diarrhea was mentioned 
on the laboratory request form). Positive samples were 
sent to the National Reference Center, where STEC strains 
were isolated and subtyped by various methods (including 
serotyping).
We calculated frequencies and proportions of STEC 
serogroups separately for food and patient isolates. Sero-
groups were compared for matches in both groups. Because 
the clinical outcome associated with human STEC infection 
was not systematically recorded, we additionally compared 
serogroups of food isolates with a compilation (available 
on the Internet) of literature reports of STEC serotypes and 
their association with human illness (7). We acknowledged 
an association with human illness if a symptom at least 
as severe as diarrhea was speciﬁ  ed for a serogroup. The 
proportion of serogroups in patient and food isolates was 
compared by using the Wilcoxon signed rank test. Within 
selected serogroups, we examined serovars (classiﬁ  ed by 
O and H antigen, e.g., O157:H7) to assess comparability 
between food and patient isolates because the serovar is a 
better proxy for genomic background of the strains than is 
the serogroup.
Serogroup information for STEC isolated from food 
was available for 448 strains (including nontypeable strains 
[Ont] and self-agglutinating isolates [Orough]), 357 from 
food source 1 and 91 from food source 2 (Table 1). The most 
common of the 61 serogroups identiﬁ  ed in food isolates 
were O8 (9%), O91 (6%), and O113 (5%) (Table 2). Com-
monalities, but also differences, were observed between the 
food sources. For example, the proportion of serogroups 
O8 and O91 was high in both food sources, whereas O113 
strains were isolated only from food source 1. Notably, 
STEC isolates from game represented 24% (85/357) of 
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ries (Table 1). Game also had the highest STEC prevalence 
among the different food categories routinely sampled by 
Germany’s food safety authorities from 2005 through 2006 
(13%, 95% conﬁ  dence interval 9%–17%) (8,9). Serogroup 
information for STEC isolates from patients was available 
for 1,447 of 1,478 (including Ont and Orough). Overall, 71 
different STEC serogroups were isolated, and O157 (18%) 
was the most frequently serotyped O-group, followed by 
O103 and O26 (14% each; Table 2). No secular trends were 
observed during the study period, but proportions of single 
serogroups varied across years, particularly for STEC O103 
isolates (range 6%–24%).
Of the 61 food serogroups, 41 (67%) were also iden-
tiﬁ   ed in patients (Figure). These serogroups comprised 
72% (242/339) of food isolates with a known serogroup. 
Similarly, 78% (19/25) of serogroups isolated from game, 
accounting for 70% (44/63) of isolates, occurred also in pa-
tients. The Internet search showed a published association 
with human illness for at least 41 (67%) of all food sero-
groups; the phrase “at least” is used because 5 serogroups 
(O174, O176-O179) were ofﬁ  cially acknowledged as gen-
uine O-groups after May 2003 (10), which according to the 
website is the date of its last update (7). Moreover, some 
serogroups exclusively found in food in this study (and not 
listed on the website) have been described as sporadic pa-
tient isolates from Germany (11) and elsewhere (12).
Overall, a signiﬁ  cant inverse correlation was found be-
tween the ranking of the serogroup proportion in patients 
and in food (p<0.01). This ﬁ  nding is illustrated by the fol-
lowing: of the 41 serogroups found in food and in patients, 
33 accounted each for <1% of the patient isolates. In total, 
they represented only 9% of patient isolates but 45% of 
food isolates. Conversely, the 3 most frequently identiﬁ  ed 
serogroups in patients, O157, O103, and O26, represented 
46% of the patient isolates but only 3% of food isolates. 
These 3 serogroups account for 85% of STEC isolated in 
pediatric HUS patients in Germany (2). Notably, the viru-
lent serogroup O157 was found in 5 (1%) food isolates. 
This result is compatible with results of studies conducted 
in other countries that identiﬁ  ed only few, if any, O157 
strains among STEC strains isolated from ruminant meat, 
particularly beef (13,14).
At least 1 serogroup, O91, was frequently isolated 
from both food and patients. In food, O91 strains were the 
second (6%), and in patients the fourth (10%), most com-
monly identiﬁ  ed O-group (and the most commonly iden-
tiﬁ  ed O-group in adults; data not shown). On the serovar 
level, a comparable distribution was observed between 
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Table 1. Foods from which STEC was isolated in Germany, 1996–2004* 
Source Origin No. ruminant samples†  Total no. samples 
Federal Institute for Risk Assessment‡  Ground beef§  112 112
Game¶ 57 85
Raw milk 55 55
Beef and beef products   43 43
Raw spreadable sausages 20 20
Pork and pork products   0 19
Cheese 15 15
Other# 2 7
Max-Rubner Institute**  Raw spreadable sausages  54 54
Raw sausage meat  34 34
Other†† 2 3
Total 395 448
*STEC, Shiga toxin–producing Escherichia coli.
†Samples from food containing ruminant meat or of ruminant origin. 
‡Isolates from governmental food inspection laboratories (2005–2007). 
§Of these, 12 contained also ground meat from sheep. 
¶Deer (n = 56), wild boar (n = 18), hare (n = 10), game unspecified (n = 1). 
#Sheep meat (n = 2), duck, salad, flan, minced horse meat, river water (1 each). 
**Isolates obtained during a series of investigations in selected meat-processing companies (1996–2004). 
††Meat juice (n = 2), horse meat (n = 1). 
Table 2. Serogroups of STEC most frequently isolated from 
patients (1999–2004) and food (1996–2007), Germany* 
Frequency ranking 
Serogroups isolated 
from patients (%) 
Serogroups isolated
from food† (%) 
1 O157 (18) O8 (9) 
2 O103 (14) O91 (6) 
3 O26 (14) O113 (5)
4 O91 (10)  O22 (4) 
5 O145 (4)  O115 (4) 
Total percentage‡  60 28
*STEC, Shiga toxin–producing Escherichia coli.
†Food categories from which strains were isolated: O8: raw spreadable 
sausage (n = 14), pork and products (n = 9), ground beef (n = 7), raw 
sausage meat (n = 5), raw milk (n = 4), game (n = 2), other (n = 1). O91: 
raw spreadable sausage (n = 14), ground beef (n = 5), raw milk (n = 3), 
game (n = 2), raw sausage meat (n = 2), other (n = 2). O113: ground beef 
(n = 10), cheese (n = 3), game (n = 3), pork and products (n = 2), beef and 
products thereof (n = 1), raw milk (n = 1), raw spreadable sausage (n = 1). 
O22: ground beef (n = 8), raw spreadable sausage (n = 6), beef and beef 
products (n = 1), game (n = 1), ground beef (n = 1), raw milk (n = 1), raw 
sausage meat (n = 1). O115: raw sausage meat (n = 12), raw spreadable 
sausage (n = 3). 
‡Percentage of all isolates for which serogroup information was available 
(1,447 isolates from patients and 448 isolates from food).  STEC Serogroups, Germany
isolates from patients and food: in both groups, the same 
3 serovars (O91:H–, O91:H14, O91:H21) could be distin-
guished; O91:H– was the most common STEC serovar in 
patient isolates (64%, 94/145) as well as in food isolates 
(47%, 19/41). A different situation was observed for STEC 
O113, the third (5%) most frequently serotyped O-group 
in food. Among patient isolates, STEC O113 was not that 
frequently isolated: the serogroup ranked 14th and com-
prised 1% of patient isolates. Furthermore, a greater het-
erogeneity between patient and food isolates was found in 
O113 strains. Although the same 3 serovars were identiﬁ  ed 
in both groups (O113:H–, O113:H4, O113:H21), O113:H4 
was the predominant STEC serovar in isolates from pa-
tients (70%, 9/13), whereas O113:H21 (81%, 17/21) was 
the most common in food isolates. The latter serovar is fre-
quently isolated from nonpediatric HUS patients (15).
Conclusions
Two thirds (41/61) of serogroups from food were also 
isolated from patients, comprising 72% of food isolates 
with a known serogroup. These serogroups included, albeit 
uncommonly, those typically identiﬁ   ed in pediatric and 
nonpediatric HUS patients. An association with human ill-
ness has been published for more than two thirds of food 
serogroups. These ﬁ  ndings suggest that many STEC strains 
isolated from food in Germany are pathogenic for humans. 
Notwithstanding, the most frequent STEC serogroups in 
patients, except O91, were only rarely found in food.
The incongruent serogroup distributions of STEC iso-
lates from food and from patients likely reﬂ  ect the non-
probabilistic sampling schemes and differing sampling 
periods that underlie these populations. In addition, differ-
ences in pathogenicity among serogroups, a different se-
rovar distribution at the serogroup level, and the fact that 
foodborne transmission is only 1 transmission route (5) 
should also contribute to the observed differences. Game 
might be a relevant, and as yet underappreciated, source for 
human STEC infection in Germany. Epidemiologic studies 
are needed to assess the risk associated with consumption 
of or contact with game.
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